Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-24 Purchase | 2024-01-26 5:40 pm | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 280,000 | $0.4996 | $139,888 | 1,375,425 (Direct) | View |
| 2023-12-15 Purchase | 2023-12-19 7:09 pm | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 595,425 | $0.31698 | $188,737 | 1,095,425 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-20 Option Award | 2024-06-24 4:07 pm | N/A 2034-06-20 | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 6:44 pm | N/A 2033-12-12 | Perspective Therapeutics Inc. | CATX | Puhlmann Markus Chief Medical Officer | 1,477,619 | $0 | 2,885,688 (Direct) | View |
Ownership | 2023-02-13 4:32 pm | N/A N/A | Isoray Inc. | ISR | Puhlmann Markus Chief Medical Officer | 0 | $0 | 1,908,069 (Direct) | View |